Glycan Changes Linked to Drug Resistance in Liver Cancer
Author Information
Author(s): Kudo Takeaki, Nakagawa Hiroaki, Takahashi Masato, Hamaguchi Jun, Kamiyama Naoya, Yokoo Hideki, Nakanishi Kazuaki, Nakagawa Takahito, Kamiyama Toshiya, Deguchi Kisaburo, Nishimura Shin-Ichiro, Todo Satoru
Primary Institution: Hokkaido University, Japan
Hypothesis
The study investigates the relationship between N-glycan alterations and drug resistance in human hepatocellular carcinoma.
Conclusion
The study found that specific N-glycan structures are increased in drug-resistant liver cancer cells, suggesting new mechanisms of drug resistance.
Supporting Evidence
- Drug-resistant cell lines showed increased core fucosylated triantennary oligosaccharides.
- Expression of glycosyltransferases involved in glycan synthesis was altered in resistant cells.
- The study identified specific N-glycan structures that may contribute to drug resistance mechanisms.
Takeaway
The study shows that certain sugars on cancer cells change when they become resistant to drugs, which might help us understand how to fight cancer better.
Methodology
The researchers created drug-resistant cell lines and analyzed their glycan structures and glycosyltransferase expression.
Statistical Information
P-Value
0.016
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website